JMS Co

JMS Co Net Debt per Share

The Net Debt per Share of JMS Co (7702.T) as of Nov 3, 2026 is 820.26 JPY. In the previous year, Net Debt per Share was 769.87 JPY — a change of 6.54% (higher).

Net Debt per Share

820.26JPY

YoY

6.54%

Last updated:

Net Debt per Share of JMS Co is 2026 820.26 JPY. Net Debt per Share of JMS Co was 2025 769.87 JPY. It decreases by 6.54% higher compared to the previous year.

The JMS Co Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2019
472.87 JPY
Jan 1, 2020
502.67 JPY
Jan 1, 2021
496.48 JPY
Jan 1, 2022
481.28 JPY
Jan 1, 2023
542.62 JPY
Jan 1, 2024
671.86 JPY
Jan 1, 2025
769.87 JPY
Jan 1, 2026
820.26 JPY
The JMS Co Net Debt per Share history
YEARNet Debt per ShareYoY
820.26JPY+6.54%
769.87JPY+14.59%
671.86JPY+23.82%
542.62JPY+12.75%
481.28JPY-3.06%
496.48JPY-1.23%
502.67JPY+6.30%
472.87JPY-5.31%
499.39JPY+7.29%
465.47JPY+8.56%
428.75JPY+31.55%
325.92JPY+20.68%
270.08JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

Net Debt per Share of JMS Co is 820.26 JPY in 2026.

Net Debt per Share of JMS Co changed from 769.87 JPY to 820.26 JPY, representing a 6.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share JMS Co since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — JMS Co

All Key Metrics — JMS Co